Arecor Therapeutics plc (LON:AREC – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as GBX 130 ($1.62) and last traded at GBX 130.24 ($1.62), with a volume of 16323 shares trading hands. The stock had previously closed at GBX 132.50 ($1.65).
Arecor Therapeutics Stock Performance
The company has a market cap of £39.82 million, a P/E ratio of -419.35 and a beta of -0.22. The company has a quick ratio of 6.24, a current ratio of 2.52 and a debt-to-equity ratio of 1.26. The stock has a 50 day moving average price of GBX 143.89 and a two-hundred day moving average price of GBX 169.05.
Arecor Therapeutics Company Profile
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.
See Also
- Five stocks we like better than Arecor Therapeutics
- Pros And Cons Of Monthly Dividend Stocks
- Silicon Motion Proves That AI in Motion Stays in Motion
- 5 discounted opportunities for dividend growth investors
- Undervalued UnitedHealth Group Won’t Be For Long
- What Does a Stock Split Mean?
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
